Top Markets
#1 Helium Helium +60.93%
#2 GEKKO GEKKO +48.56%
#3 Pons Pons +41.70%
#4 ADO Protocol ADO Protocol +39.04%
#5 Prom Prom +37.33%
#6 TENDIES TENDIES +31.81%
#7 StonkBroker StonkBroker +30.27%
#8 Collector Crypt Collector Crypt +29.05%
#9 Collect on Fanable Collect on Fanable +23.84%
#10 龙虾 (Lobster) 龙虾 (Lobster) +21.43%
Coin of the day
Helium Helium
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Jenkem Technology Co., Ltd. Jenkem Technology Co., Ltd.

Jenkem Technology Co., Ltd.

688356
Classifica tra le azioni #9739
Jenkem Technology Co., Ltd., together with its subsidiaries, engages in the... Jenkem Technology Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of medical and pharmaceutical polyethylene glycol derivative (PEG) products in China and internationally. The company offers high molecular weight polyethylene glycol derivatives comprising branched, methoxylated, bifunctionalized, heterofunctionalized disubstituted, multi-arm, multi-arm heterofunctional disubstituted, amino-polyglycolic, N-terminated polyethylene glycol-modified, and thiol-modified polyethylene glycol PEG products; monodisperse PEG products consisting of methoxy monodisperse PEG derivatives, and monodisperse PEG derivatives with the same functional and heterofunctional groups; click chemistry; lipid nanoparticles delivery system accessories; PEG linkers, such as ADC and PROTAC linkers; PEG medical devices, which include multi-arm PEG derivatives; polyethylene glycol standards; block copolymers; PEG standards; long-acting polypeptide fatty acid side chains, including semaglutide, tirzepatide/icodec, and somapacitan intermediates; and Silkrose injectable cross-linked sodium hyaluronate gel, a passive implantable device used to correct moderate to severe nasolabial folds through subcutaneous injection. It also provides technical services comprising development of synthetic methods, quality research and IND application, analytical method development, and polyethylene glycolization technology services. Jenkem Technology Co., Ltd. was incorporated in 2001 and is headquartered in Beijing, China.
Prezzo delle azioni
$15.77
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$956.26M
Variazione (1 giorno)
-14.53%
Variazione (1 anno)
26.32%
Paese
CN
Scambia Jenkem Technology Co., Ltd. (688356)

Categoria

Healthcare
Utile per Jenkem Technology Co., Ltd. (688356)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Jenkem Technology Co., Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Jenkem Technology Co., Ltd. dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT